Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.06.024 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Min Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China. Hauptthemen laut MEDLINE: Cytokines, Single-Domain Antibodies, Inflammation, Asthma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Science and Technology Development Foundation, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China.
- School of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China. Electronic address: ykwan@novamab.com.
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Science and Technology Development Foundation
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
Zitieren
APA
Zhu, M., Ma, L., Gai, J., Li, G., Huang, J., Li, X., Qiao, P., Su, J., Pei, S., & Wan, Y. (2025). Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.06.024
Vancouver
Zhu M, Ma L, Gai J, Li G, Huang J, Li X, et al. Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.06.024
BibTeX
@article{Zhu2025,
author = {Zhu, Min and Ma, Linlin and Gai, Junwei and Li, Guanghui and Huang, Jing and Li, Xiaofei and Qiao, Peng and Su, Juan and Pei, Siran and Wan, Yakun},
title = {Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.06.024}
}
EUVIMED